SCHEMBL997844

SCHEMBL997844

CC(N)(C=O)CN1CCn2c(nc(-c3c(F)cc(F)cc3F)c2Nc2ccc(F)cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 13/20 0.50
CYP3A4 P08684 1/20 0.36
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPK14 Q16539 1/20 0.30
GRM2 Q14416 1/20 0.30
AXL P30530 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000957 0.84 KCNH2 (0.57) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL997446 0.82 KCNH2 (0.53) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL17626234 0.82 KCNH2 (0.55) KCNH2CYP3A4ALDH1A1GRM2
SCHEMBL997843 0.79 KCNH2 (0.79) KCNH2CYP3A4
SCHEMBL999239 0.76 KCNH2 (0.58) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL1051396 0.76 KCNH2 (0.60) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL997932 0.72 KCNH2 (0.63) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL12781375 0.69 KCNH2 (0.39) KCNH2CYP3A4
SCHEMBL2070050 0.69 KCNH2 (0.87) KCNH2CYP3A4
SCHEMBL998969 0.68 KCNH2 (0.60) KCNH2CYP3A4ALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451814-A2 FUSED IMIDAZOLES AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS E.G. MALARIA IRM LLC (BM) 2012-05-16 EP disclosed
WO-2011006143-A2 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES IRM LLC (BM) 2011-01-13 WO disclosed